Manus Secures Over $500M in First Raise Since Meta Deal Collapsed

Manus is back in business, and investors have decided the regulatory drama of the past year hasn't dented its appeal.

Butterfly Effect, the parent company behind the Chinese AI agent startup, confirmed on Thursday via a WeChat post that it raised more than $500 million. It's the company's first capital infusion since Beijing forced Meta to abandon its planned $2 billion acquisition earlier this year. Boyu Capital and IDG Capital led the round, with existing backers Tencent, HSG (the firm formerly known as Sequoia China), and ZhenFund returning to the table.

Manus didn't disclose a valuation figure in its announcement. That's notable given reporting last month indicated the company was in talks to raise exactly this amount, $500 million, at a $4 billion valuation. The silence on numbers, despite confirming the raise itself, suggests either ongoing negotiation sensitivity or a deliberate choice to let the deal speak for itself before formalizing terms publicly. TechCrunch reached out to Manus for comment on valuation and received no response.

The Meta Deal and Its Unwinding

The backstory here matters for understanding why this raise carries weight beyond its dollar figure.

Manus built its reputation on a viral AI agent demo last year, the kind of product moment startups chase for years and rarely achieve. By mid-2025, the company had relocated staff to Singapore, a move that in hindsight looks like early positioning ahead of the deal to come. That December, Manus announced Meta would acquire it for $2 billion, with the startup reportedly generating annual recurring revenue north of $100 million at the time, a healthy multiple-of-revenue signal for a fast-growing AI shop.

Then came April. Chinese authorities vetoed the Meta transaction after a months-long probe, citing concerns over losing AI talent and research capability to Western competitors. This wasn't a minor regulatory hiccup. It reflects a broader pattern of Beijing tightening control over strategic technology assets, particularly those with acquisition interest from U.S. tech giants. For Manus, the veto meant unwinding a deal that had already been publicly announced and presumably priced into expectations among employees and early investors.

Manus resumed independent operations in August, and the split required the company to delete some user data as part of the separation from Meta, per the company's own blog post. That's an operational detail worth flagging: data deletion requirements in corporate unwinds aren't typically trivial, and they can create friction with enterprise customers or complicate product continuity. The company is also reportedly weighing a Hong Kong IPO, though details on timing remain scarce.

What's striking is how quickly Manus moved from regulatory limbo to a nine-figure raise. Five months between resuming independent operations and closing $500 million is a fast turnaround, and it signals investor confidence that the Meta episode was a geopolitical speed bump rather than a fundamental flaw in the business.

The product itself continues to evolve. Manus competes in the increasingly crowded AI coding and agent space alongside Cursor, Lovable, and Replit, offering a chatbot plus vibe-coding tools for building apps, generating designs, and producing video content. The company recently launched Manus 2.0, described as a new architecture with fresh capabilities built around a new technical harness. It also introduced Cue, a standalone app giving personal AI agents their own email addresses, phone numbers, digital wallets, and computing resources, allowing agents to transact and communicate across services within user-set limits.

Key Figures

The headline numbers here are straightforward but worth isolating. More than $500 million raised. A reported target valuation of $4 billion, unconfirmed by the company. Annual recurring revenue said to exceed $100 million as of the Meta deal announcement roughly ten months ago. And a prior acquisition price tag of $2 billion that regulators rejected outright.

Run those figures against each other and a picture emerges. If the $4 billion valuation holds, Manus has roughly doubled its implied worth since the Meta offer, despite, or perhaps because of, the regulatory interference. That's an unusual outcome. Typically, a blocked acquisition signals risk and depresses investor appetite. Here, the opposite appears true: Boyu Capital, IDG Capital, Tencent, and HSG all returned or newly committed capital at a valuation well above what Meta was willing to pay.

The revenue multiple implied by $4 billion against $100 million-plus ARR sits around 40x or higher, depending on how much revenue has grown since the Meta deal was first struck. That's rich even by AI startup standards, and it assumes continued rapid growth. Investors underwriting this round are betting heavily on Manus's ability to scale both domestically and abroad, which the company has explicitly flagged as a hiring priority.

Investment Implications

For investors tracking China's AI sector, Manus is a useful bellwether. The regulatory veto demonstrated that Beijing will intervene decisively when it perceives strategic technology leaking to U.S. acquirers, even at the cost of blocking a deal already announced to the market. That's a risk factor any investor in Chinese AI startups with cross-border ambitions needs to price in explicitly, not as an afterthought.

At the same time, the speed and size of this raise suggest domestic capital is ready to step in where foreign acquirers cannot. Tencent's continued participation is particularly telling: it signals confidence from one of China's most sophisticated technology investors that Manus's underlying product and revenue trajectory justify a valuation double what Meta offered less than a year ago.

The potential Hong Kong listing adds another dimension worth watching. An IPO there would give Manus a path to liquidity without needing Western regulatory approval, and it would test public market appetite for AI agent companies at scale. Given the richness of the implied valuation here, that test will be a meaningful one. Investors should watch for formal valuation confirmation, updated ARR figures, and any concrete IPO timeline as the clearest signals of whether this round's pricing holds up under scrutiny.